Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

• Status: Not yet recruiting
• Trial end date: 2027-06-30

Summary

The purpose of this study is to compare the efficacy and toxicity of early stage endometrial cancer based on molecular classification and conventional risk stratification adjuvant therapy decision-making, and to provide high-quality evidence-based medical evidence for individualized adjuvant therapy selection under the guidance of fine stratification system of endometrial cancer.

• Phase: Phase 3

Details

• Lead Sponsor: Peking Union Medical College Hospital
• Collaborators: First Affiliated Hospital Xi'an Jiaotong University; Gansu Cancer Hospital; General Hospital of Ningxia Medical University; Peking University First Hospital; The 940th Hospital of Joint Logistics Support Force，PLA.; The Affiliated Hospital of Inner Mongolia Medical University; The Second Affiliated Hospital of Dalian Medical University; The second hospital Affiliated by Jilin University; Third Affiliated Hospital of Xinjiang Medical University; Xiangya Hospital of Central South University; Xijing Hospital, Air Force Medical University of PLA